Recursion Pharmaceuticals, Inc.(RXRX)
NASDAQ

Fundamental Analysis & Financials

$3.41
0.35 (11.44%)

Valuation Snapshot

What the multiples imply about expectations

The market considers the company to be a smaller player with a significant market presence. At current multiples, it trades fairly valued—reflecting market expectations.

Valuation Metrics

Ratios and multiples

Forward P/E
-3.65
EV/Revenue (TTM)13.05

Financial Health

Liquidity and leverage

ROE (TTM)-59.54%
ROA (TTM)-27.72%
Debt/Equity (MRQ)6.89

The company's financial health appears moderate. Moderate ROE and moderate ROA reflect reasonably efficient capital use. Debt is elevated but represents structural leverage for shareholder return strategy (buybacks) rather than operational stress.

Valuation Multiples

Current valuation metrics

P/B Ratio1.45
P/S Ratio22.00
EV/EBITDA-1.73

Quarterly Earnings History

Recent quarterly financial performance and trends

Latest Quarter
Q4 2025
Revenue (TTM)
$35.35M
Net Income (TTM)
$-108.12M
EPS (Diluted)
$-0.21
QuarterRevenueNet IncomeGross ProfitEPS (Basic)EPS (Diluted)Gross MarginNet Margin
Q4 2025(Latest)$35.35M$-108.12M$21.08M$-0.21$-0.2159.6%-305.9%
Q3 2025$4.98M$-162.25M$-9.70M$-0.36$-0.36N/A-3256.1%
Q2 2025$19.10M$-171.90M$-1.06M$-0.41$-0.41N/A-899.8%
Q1 2025$14.82M$-202.49M$-7.01M$-0.50$-0.50N/A-1366.5%
Q4 2024$4.51M$-178.91M$-8.28M$-0.53$-0.53N/A-3966.0%

Key Insights:

  • Revenue increased by 609.4% from previous quarter
  • Net margin of -305.9% indicates low profitability
  • EPS improved by 41.7% quarter-over-quarter

Financial Efficiency

Utilization and collections performance

Asset Turnover 0.05 indicates low efficiency. Working Capital Turnover 0.11 is moderately efficient. ROIC -56.1% highlights weak capital returns.

Efficiency Metrics

Asset Turnover0.05
Working Capital Turnover0.11
ROIC (TTM)-56.1%

Profitability & Growth

Margins and earnings power

Revenue (TTM)
$74.68M
6.82 YoY
Profit Margin (TTM)
0.00%
Operating Margin (TTM)
-328.80%
Gross Profit (TTM)
-$471.54M
Gross Margin 0.00%
EBITDA (TTM)
-$564.43M
EBITDA Margin 0.00%
Net Income (TTM)
-$644.76M

Efficiency Performance Matrix

4-quadrant analysis of operational efficiency vs profitability

Efficiency vs Profitability Quadrants

High Efficiency
High Margin
High Efficiency
Low Margin
Low Efficiency
High Margin
Low Efficiency
Low Margin

Efficiency Analysis

Asset Turnover
Efficiency:0.05x
Margin:0.0%
Quadrant:Weak Operations
Receivables Turnover
Efficiency:NaNx
Margin:-328.8%
Quadrant:Unknown
Working Capital
Efficiency:0.11x
Margin:0.0%
Quadrant:Weak Operations
Overall Efficiency Score

Operationally weak with structural efficiency and margin issues

⚠️ Thresholds are benchmark-based heuristics derived from long-term industry averages, not strict valuation rules.

• Bubble size represents ROIC magnitude

• Green (Optimal): Excellent efficiency-profitability balance

• Blue (Efficiency-Driven): High turnover, room to improve margins

• Yellow (Margin-Driven): Strong margins, opportunity to improve efficiency

• Red (Weak Operations): Areas needing improvement on both dimensions

Market Data & Share Structure

Comprehensive valuation metrics and ownership breakdown

Market Data & Capitalization

Market Cap
$1.64B
Mega-cap: Premium liquidity & institutional favorite
Enterprise Value
$974.88M
EV 41% < Market Cap: Net cash position
Next Earnings Date
02/25/2026
Earnings date has passed - awaiting update

Share Statistics & Ownership

Shares Outstanding
N/A
Total shares issued and held by all shareholders
Shares Float
N/A
Shares available for public trading
Institutional Ownership
N/A
Held by funds, pensions, endowments
Insider Ownership
N/A
Held by executives and board members
Shares Short
N/A
Shares sold short - bearish bets
Implied Shares Outstanding
N/A
Calculated from market cap and price

Profitability Margin Pyramid

Hierarchical view of margin compression from revenue to net income

Margin Hierarchy by Profitability Level

100.0%
Revenue
$74.68M
0.0%
Gross Profit
-$471.54M
0.0%
EBITDA
-$564.43M
0.0%
Net Income
-$644.76M
Margin Profile:
Revenue100.0% margin (Top line revenue generation)
Gross Profit0.0% margin (Revenue minus cost of goods sold)
EBITDA0.0% margin (Earnings before interest, taxes, depreciation, and amortization)
Net Income0.0% margin (Bottom line profitability after all expenses)

Margin Analysis

Total Revenue

Amount:$74.68M
Margin:100.0%
Top line revenue generation

Gross Profit

Amount:-$471.54M
Margin:0.0%
Revenue minus cost of goods sold

EBITDA

Amount:-$564.43M
Margin:0.0%
Earnings before interest, taxes, depreciation, and amortization

Net Income

Amount:-$644.76M
Margin:0.0%
Bottom line profitability after all expenses

Margin Quality Assessment

Thin margins indicating potential profitability challenges

• Larger circles represent higher dollar amounts

• Margin percentages show profitability at each level

• Blue: Revenue base

• Green: Gross profitability

• Yellow: Operating performance

• Red: Net profitability

Operating Cash & Liquidity

Core cash generation and short-term solvency

Cash Flow Analysis

Operating Cash Flow (TTM)

$-371.81M

Cash from core operations

Free Cash Flow (TTM)

$-208.52M

Available after capex

Financial Position & Liquidity

Current Ratio

5.50

Healthy

Quick Ratio

5.20

Strong

Net Cash

$665.33M

Net creditor

Total Cash

$743.29M

Balance sheet cash

Total Debt

$77.97M

Outstanding borrowings

Dividends & Shareholder Returns

Policy stance and implications

The company does not currently pay a regular dividend — prioritizing reinvestment for growth. This makes it attractive for growth investors, while income-oriented investors may prefer peers with dividend payouts.